Serum Levels of IGF-1 and IGFBP-3 in Relation to Clinical and Pathobiological Aspects of Head and Neck Squamous Cell Carcinomas.

导出原文传递

翻译打印收藏纠错

作者： David,Kalfert ^[1] ; Marie,Ludvikova ^[2] ; Ondrej,Topolcan ^[3] ; Petr,Celakovsky ^[4] ; Radek,Kucera ^[2] ; Jindra,Windrichova ^[4] ; Jaroslav,Ludvik ^[4] ; Katerina,Skalova ^[5] ; Vlastimil,Kulda ^[2] ; Martin,Pesta ^[6] ; Jan,Plzak ^[7]

作者单位： Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Motol, First Faculty of Medicine, Charles University, Prague, Czech Republic. ^[1] Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Hradec Kralove, Faculty of Medicine in Hradec Kralove, Charles University, Prague, Czech Republic. ^[2] Department of Biology, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic ludvikova.m@mail.cz marie.ludvikova@lfp.cuni.cz. ^[3] Department of Immunochemistry, University Hospital Pilsen, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic. ^[4] Department of Imaging Methods, University Hospital Pilsen, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic. ^[5] Department of Medical Chemistry and Biochemistry, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic. ^[6] Department of Biology, Faculty of Medicine in Pilsen, Charles University, Prague, Czech Republic. ^[7]

关键词 Head and neck squamous cell carcinoma IGF-1 IGFBP-3 p16 serum tumor marker